The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Steady improvement to higher margin business.
Motoring up. Something is driving this upwards. Momentum player. Looking good. Relative strength as a % in one week is a pleasing 17.6%.
Market cap still looks unjustifiably low. Turnover, profits and dividends on the way up.
Private equity may be on the prowl. Shame really as the company has worked hard, to be on the cusp of significant progress.
This is going well, topped up yesterday and today. I am sure this will be 20p plus in a few weeks. There business is in for a massive boom.
Its the time to buy in, all time low and very positive news. Re-rate on cards. Bought at 10.5p
Do some research and decide!!
The Group's performance is above the Board's post-pandemic expectations, and
the strong increase in order activity in March improved the overall orderbook
to approximately $14 million as at 31 March 2021, almost 70% above the prior
year.
As the economies reopen , the prospects for a return to significant dividends are high.
Would be positive to see director purchases.
Possibly clash of vision for company.
To lose one CFO may be regarded as a misfortune, but to lose 2 in less than 2 months looks like ? Why did Mitch leave, anyone ?
Single share would be the highest volume traded for whole week.
who in their right mind buys a single share?
Hi Guys, Do you think 600 sp will hold up now we have left EU.as I believe they have considerable investment
in EU companies any thoughts welcome.
Definitely a good move. Missed the initial company announcement on London Stock Exchange and London South East sites as it appears as a RNS-Reach rather than a RNS, and the RNS-Reach announcements do not appear in some company news item lists.
The technical barrier to overcome if that price occurs again. 44m warrants at that level
From Hardman and Director's talk, it will be wound up in April. In addition, the restructuring of its 2020 Loan Notes frees up the money from the buyout of the pension scheme liability to use for possible acquisitions, and also provides greater financial flexibility for the group.
What a poor deal on pension fund. Should have got £8m. Must be desperate for cash to pay Dopeys salary.
Anyone know when Finals due ? 4/7 last year.
Tipped again by Master Investor. Price seems to be moving in the right direction. Good slow burn in my opinion.
How much did they pay Hardman to write the report ?
Just written a very positive out look for SIXH. I think these are going to double in price in the next couple of years. I have added and going to keep for next couple of years.
Good right up on Master Investor 600 Group (LON:SIXH) this morning report their six months to 30th September 2017. These figures are not stellar but they are very encouraging. There are a couple of exceptional items but, allowing for these, EPS is at 0.8p per share. Doubling this to 1.6p for a full year gives a PE of 10 at 16p. At 16p SIXH is capitalised at �17 million in contrast to tangible net asset value of the order of �38 million. This share price is far too low. 25p would be more in point.
Must have been even more desperate for cash than my post of yesterday summised. Not only the PPIX giveaway but now an additional discount placing of almost 8% of company at 13p (sp 14.5) ! Wish Cinderella would take Dupey back.
Must be desperate for cash. PPIX was 20p recently but SIXH only got 7p. PPIX was always very illiquid, but even so, would have thought that SIXH could have done a lot better. Not surprised sp is heading south.
Sold off its entire holding in laser diode and LED systems manufacturer ProPhotonix for £1.5m, which results in a £1m profit in the consolidated income statement, howver, proceeds will be used to reduce the debt.
Moving a bit today